RHOT1 and neoplasm: Additionally, the results showed that no significant association was observed between the cytoplasmic expression levels of RhoT1, Smad4, p16 and clinicopathological features, which including age, gender, tumor location, size, tumor differentiation, and AJCC stage (all P>0.05; Table 4).